Sale
Massive Discounts! Up to 50% OFF on reports🎉

Non Small-Cell Lung Cancer Market Size, Share, Industry Trends, Growth Opportunities and Forecast 2024 - 2031

Global Non Small-Cell Lung Cancer Market is Segmented By Drug Class(Epidermal Growth Factor Receptor (EGFR) Inhibitors, Anaplastic Lymphoma Kinase (ALK) Inhibitors, ROS1 Inhibitors, BRAF Inhibitors, Others), By Type(Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Others), By Treatment(Chemotherapy, Targeted Therapy, Immunotherapy), By End-user(Hospitals, Homecare, Specialty Clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published: December 2024
SKU : PH945
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s

Related Reports
pharmaceuticals

Lung Cancer Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 27
Starting from

$4350

medical-devices

Lung Cancer Surgery Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 30
Starting from

$4350

pharmaceuticals

Cancer Diagnostic Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 December 09
Starting from

$4350

pharmaceuticals

Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 December 17
Starting from

$4350

pharmaceuticals

Silent Cancer Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 August 01
Starting from

$4350

pharmaceuticals

Cancer Stem Cell Therapy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 June 18
Starting from

$4350